Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice

Volume: 11, Issue: 1
Published: Nov 2, 2021
Abstract
Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from self or donors have their own advantages and disadvantages in their medical practice. Therapeutic benefits of using autologous vs. allogeneic MSCs are inconclusive. Transplanted MSCs within the body interact with their physical microenvironment or niche,...
Paper Details
Title
Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
Published Date
Nov 2, 2021
Journal
Volume
11
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.